Wells Fargo’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$97.7M Buy
597,384
+10,733
+2% +$1.65M 0.02% 642
2025
Q4
$102M Buy
586,651
+72,802
+14% +$13.3M 0.02% 613
2025
Q3
$74M Buy
513,849
+254,642
+98% +$31.2M 0.01% 729
2025
Q2
$26.1M Buy
259,207
+53,696
+26% +$4.11M 0.01% 1227
2025
Q1
$15.7M Buy
205,511
+44,802
+28% +$3.43M ﹤0.01% 1510
2024
Q4
$11.1M Buy
160,709
+33,214
+26% +$2.39M ﹤0.01% 1789
2024
Q3
$9.31M Sell
127,495
-81,635
-39% -$6.02M ﹤0.01% 1883
2024
Q2
$14M Buy
209,130
+137,677
+193% +$5.34M ﹤0.01% 1488
2024
Q1
$1.94M Sell
71,453
-24,894
-26% -$697K ﹤0.01% 2996
2023
Q4
$2.99M Sell
96,347
-17,249
-15% -$447K ﹤0.01% 2590
2023
Q3
$2.87M Sell
113,596
-30,116
-21% -$689K ﹤0.01% 2516
2023
Q2
$3.03M Buy
143,712
+27,056
+23% +$513K ﹤0.01% 2565
2023
Q1
$1.99M Buy
116,656
+95,574
+453% +$1.86M ﹤0.01% 2864
2022
Q4
$421K Sell
21,082
-4,827
-19% -$93.3K ﹤0.01% 3740
2022
Q3
$558K Sell
25,909
-564
-2% -$13.5K ﹤0.01% 3627
2022
Q2
$521K Sell
26,473
-53,435
-67% -$1.12M ﹤0.01% 3719
2022
Q1
$1.88M Sell
79,908
-39,224
-33% -$911K ﹤0.01% 3365
2021
Q4
$3.25M Sell
119,132
-34,903
-23% -$998K ﹤0.01% 3009
2021
Q3
$4.24M Sell
154,035
-78,729
-34% -$2.07M ﹤0.01% 2995
2021
Q2
$6.63M Buy
232,764
+6,793
+3% +$202K ﹤0.01% 2588
2021
Q1
$7.7M Sell
225,971
-26,013
-10% -$994K ﹤0.01% 2434
2020
Q4
$8.39M Buy
251,984
+104,232
+71% +$3.81M ﹤0.01% 2243
2020
Q3
$4.75M Buy
147,752
+36,154
+32% +$1.04M ﹤0.01% 2557
2020
Q2
$3.07M Buy
111,598
+38,298
+52% +$908K ﹤0.01% 2914
2020
Q1
$1.18M Sell
73,300
-31,499
-30% -$747K ﹤0.01% 3432
2019
Q4
$2.5M Sell
104,799
-9,763
-9% -$199K ﹤0.01% 3171
2019
Q3
$2.02M Buy
114,562
+27,939
+32% +$540K ﹤0.01% 3326
2019
Q2
$2.22M Buy
86,623
+23,816
+38% +$663K ﹤0.01% 3263
2019
Q1
$1.83M Sell
62,807
-66,640
-51% -$1.73M ﹤0.01% 3434
2018
Q4
$1.7M Buy
129,447
+67,836
+110% +$1.08M ﹤0.01% 3397
2018
Q3
$1.25M Buy
61,611
+18,388
+43% +$415K ﹤0.01% 3801
2018
Q2
$1.02M Sell
43,223
-15,177
-26% -$391K ﹤0.01% 3978
2018
Q1
$1.31M Buy
58,400
+14,637
+33% +$385K ﹤0.01% 3699
2017
Q4
$1.36M Sell
43,763
-6,177
-12% -$182K ﹤0.01% 3688
2017
Q3
$1.56M Buy
49,940
+5,377
+12% +$102K ﹤0.01% 3493
2017
Q2
$765K Sell
44,563
-331
-0.7% -$5.65K ﹤0.01% 3928
2017
Q1
$786K Sell
44,894
-162
-0.4% -$2.5K ﹤0.01% 3923
2016
Q4
$597K Buy
45,056
+20,661
+85% +$282K ﹤0.01% 4078
2016
Q3
$355K Buy
24,395
+3,882
+19% +$48.6K ﹤0.01% 4145
2016
Q2
$202K Sell
20,513
-3,654
-15% -$42.6K ﹤0.01% 4407
2016
Q1
$306K Buy
24,167
+2,520
+12% +$33.1K ﹤0.01% 4153
2015
Q4
$393K Buy
21,647
+4,007
+23% +$70.6K ﹤0.01% 4055
2015
Q3
$328K Sell
17,640
-5,005
-22% -$125K ﹤0.01% 4201
2015
Q2
$553K Buy
22,645
+20,045
+771% +$455K ﹤0.01% 4021
2015
Q1
$54K Buy
2,600
+303
+13% +$5.34K ﹤0.01% 4977
2014
Q4
$36K Buy
2,297
+490
+27% +$6.95K ﹤0.01% 5149
2014
Q3
$24K Sell
1,807
-987
-35% -$14.9K ﹤0.01% 5218
2014
Q2
$56K Sell
2,794
-2,127,217
-100% -$31.5M ﹤0.01% 4928
2014
Q1
$40.6M Buy
2,130,011
+222,232
+12% +$4.22M 0.02% 864
2013
Q4
$32.4M Buy
+1,907,779
New +$29.2M 0.01% 957

Other funds holding INSM

Wells Fargo's INSM Position: Q1 2026 in Review

Wells Fargo increased its Insmed (INSM) stake by 1.8% in Q1 2026, buying an estimated $1.65M and bringing the position to 597,384 shares worth $97.7M. The position accounts for 0.02% of the portfolio, ranked #642.

Wells Fargo first reported a position in INSM in Q4 2013 and has held it in 50 quarters since. The position peaked at $102M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Wells Fargo held 597,384 shares of Insmed worth $97.7M as of Q1 2026.
  • Wells Fargo bought 10,733 Insmed shares in Q1 2026, an estimated $1.65M.
  • Insmed made up 0.02% of Wells Fargo's portfolio in Q1 2026, its #642 holding.
  • Wells Fargo first reported a position in Insmed in Q4 2013 and has held it in 50 quarters since.
  • Wells Fargo's Insmed position peaked at $102M in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.